Who Owns Patent for Insulin? Discover the Major Players and Their Impact on Pricing
Explore the intricate history of insulin patent ownership, from its discovery by Banting and Best to today’s leaders like Eli Lilly and Novo Nordisk. Understand how patents influence drug pricing and accessibility, the role of major pharmaceutical companies, key legal battles, and the rise of biosimilars. Gain valuable insights into the evolving insulin market and its impact on diabetes care and affordability.


























































